LDL-Based Lipid Nanoparticle Derived for Blood Plasma Accumulates Preferentially in Atherosclerotic Plaque
Apolipoprotein-based drug delivery is a promising approach to develop safe nanoparticles capable of targeted drug delivery for various diseases. In this work, we have synthesized a lipid-based nanoparticle (NPs) that we have called “Aposomes” presenting native apolipoprotein B-100 (apoB-100), the pr...
Guardado en:
Autores principales: | Christian A. Boada, Assaf Zinger, Scott Rohen, Jonathan O. Martinez, Michael Evangelopoulos, Roberto Molinaro, Madeleine Lu, Ramiro Alejandro Villarreal-Leal, Federica Giordano, Manuela Sushnitha, Enrica De Rosa, Jens B. Simonsen, Sergey Shevkoplyas, Francesca Taraballi, Ennio Tasciotti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1431445ef19540ffbdf36c33e227fd00 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ON THE POSSIBILITY OF USING CARBON ENTEROSORBENTS TO NORMALIZE CHOLESTEROL METABOLISM
por: N. V. Sych, et al.
Publicado: (2021) -
Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer
por: Alessandro De Vita, et al.
Publicado: (2021) -
Un sistema de trazabilidad basado en web para la genética de ganado en Panamá
por: Vladimir Villarreal, et al.
Publicado: (2016) -
Concentración sérica de apolipoproteínas A-I y B en niños y adolescentes
por: Casanueva E,Victor, et al.
Publicado: (1995) -
Integrating continuous hypermutation with high‐throughput screening for optimization of cis,cis‐muconic acid production in yeast
por: Emil D. Jensen, et al.
Publicado: (2021)